Inhibitors of the Sulfur Assimilation Pathway in Bacterial Pathogens as Enhancers of Antibiotic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|2|187-213

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.2, 2014-12, pp. : 187-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome

By Spanu T.   Santangelo R.   Andreotti F.   Cascio G.L.   Velardi G.   Fadda G.  

International Journal of Antimicrobial Agents, Vol. 23, Iss. 2, 2004-02 ,pp. : 120-128

Elsevier

Access to resources Recommend Favorite

Tailoring an Antibacterial Peptide of Human Lysosomal Cathepsin G to Enhance its Broad-Spectrum Action Against Antibiotic-Resistant Bacterial Pathogens

By  

Current Pharmaceutical Design, Vol. 8, Iss. 9, 2002-04 ,pp. : 695-702

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics of bacterial pathogens

By Cash Phillip  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 461-473

Informa Healthcare

Access to resources Recommend Favorite

mTOR pathway inhibitors in cancer therapy: moving past rapamycin

By Wacheck Volker  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1189-1191

Future Medicine

Access to resources Recommend Favorite

Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3390-3392

Blackwell Publishing

Access to resources Recommend Favorite